Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Pamela Becker is a faculty member in the Department of Clinical Medicine at the University of California Irvine, USA. Her research primarily focuses on acute myeloid leukemia, including studies on FLT3 inhibitors, cytokine blockade therapy, and personalized treatment strategies. Recent articles published by Professor Becker delve into topics such as the impact of transplantation on treatment outcomes and the role of measurable residual disease in patient relapse.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Roland B. Walter

University of Washington

UNITED STATES

View details

Tara Lin

University of Kansas Medical Center

UNITED STATES

View details

Ryan D. Cassaday

Washington University School of Medicine

UNITED STATES

View details

Jacob Appelbaum

Assistant Professor

University of Washington

UNITED STATES

View details

Piyanuch Kongtim

UNITED STATES

View details

Amer M. Zeidan

Yale University School of Medicine

UNITED STATES

View details

Susan O’Brien

UNITED STATES

View details

Megan Othus

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Jian Ma

Ray and Stephanie Lane Professor of Computational Biology

Carnegie Mellon University

UNITED STATES

View details

Lawrence Liu

Assistant Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pamela Becker

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Allogeneic transplantation provides added benefit to FMS‐like tyrosine kinase 3 (FLT3) inhibitors for both low‐intensity and high‐intensity regimens in FLT3‐mutated acute myeloid leukemia

VenEx precisely predicts ven-aza response

Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder

Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies

CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function

Unsupervised discovery of dynamic cell phenotypic states from transmitted light movies

90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Collaborators (10)

Roland B. Walter

Tara Lin

Ryan D. Cassaday

Jacob Appelbaum

Piyanuch Kongtim

Amer M. Zeidan

Susan O’Brien

Megan Othus

Jian Ma

Lawrence Liu

Make your next move.